-

06:58:29 PM

Latest ENDP Stock Market News

ENDP - Endo International plc

07/29/21 9:00 AM

Nasdaq : ENDP

Endo Presents New Investigational Collagenase Clostridium Histolyticum Data at the American Podiatric Medical Association Annual Scientific Meeting

Encouraging Phase I safety and tolerability results of CCH as a nonsurgical treatment of plantar fibromatosis Research to continue to Phase II; retreatment phase also is ongoing in eligible patients Endo International plc (NASDAQ:ENDP) announced today initial

RHEA-AI

neutral

07/22/21 12:33 PM

Nasdaq : ENDP

Endo Announces Agreement in Principle to Settle Tennessee State Court Case

Endo International plc (NASDAQ: ENDP) today announced that its wholly-owned subsidiaries Endo Health Solutions Inc. and Endo Pharmaceuticals Inc. (collectively, "Endo") have reached an agreement in principle to settle an opioid-related case originally captioned

RHEA-AI

negative

07/15/21 6:56 PM

Nasdaq : ENDP

Endo Comments on Tennessee Appeals Court Orders

Endo International plc (NASDAQ: ENDP) today announced the issuance of several orders by the Tennessee Supreme Court and the Tennessee Court of Appeals regarding a default judgment order on liability entered by the Circuit Court for Sullivan County, Tennessee in

RHEA-AI

very negative

06/24/21 5:00 PM

Nasdaq : ENDP

earnings

Endo to Announce Second Quarter 2021 Financial Results

Endo International plc (NASDAQ: ENDP) will announce its second–quarter 2021 financial results on August 5, 2021 after the U.S. financial markets close and members of its senior management team will host a conference call and webcast on August 6, 2021 at 7:30am

RHEA-AI

neutral

06/24/21 7:30 AM

Nasdaq : ENDP

Endo's Qwo® (collagenase clostridium histolyticum-aaes) Data to Be Presented at Cosmetic Bootcamp 2021

Endo International plc (NASDAQ:ENDP) announced today that data from studies of Endo Aesthetics' Qwo ® (collagenase clostridium histolyticum-aaes), which received FDA approval in July 2020 for the treatment of moderate to severe cellulite in the buttocks of

RHEA-AI

neutral

06/11/21 6:51 PM

Nasdaq : ENDP

Tennessee Court Of Appeals Issues Orders Regarding State Court Default Judgment Against Endo

Endo International plc (NASDAQ: ENDP) today announced that the Tennessee Court of Appeals recently issued several orders with respect to a default judgment order on liability entered by the Circuit Court for Sullivan County, Tennessee in April 2021 against its

RHEA-AI

very negative

05/06/21 4:15 PM

Nasdaq : ENDP

earnings

Endo Reports First-Quarter 2021 Financial Results And Updates 2021 Financial Guidance

Endo International plc (NASDAQ: ENDP) today reported financial results for the first-quarter ended March 31, 2021. "I am proud of the continued strong execution across each of Endo's business segments as reflected by our better than expected first-quarter 2021

RHEA-AI

neutral

05/03/21 6:00 AM

Nasdaq : ENDP

Maverix Private Equity Announces Team Additions

TORONTO, May 3, 2021 - Maverix Private Equity, a Toronto-based private equity firm which recently announced an inaugural USD $500 million growth-fund, has today announced the addition of Michael Wasserman as a Managing Partner, joining Founder John Ruffolo and Mark Maybank. Michael is

RHEA-AI

neutral

04/29/21 7:30 AM

Nasdaq : ENDP

Endo's Qwo® (collagenase clostridium histolyticum-aaes) Data to Be Presented at The Aesthetic Meeting 2021

Endo International plc (NASDAQ: ENDP) announced today that data relevant to the use of Endo Aesthetics' Qwo ® (collagenase clostridium histolyticum-aaes), which received FDA approval in July 2020 for the treatment of moderate to severe cellulite in the

RHEA-AI

neutral

04/27/21 4:15 PM

Nasdaq : ENDP

Endo Implements Board Succession Plan

Endo International plc (NASDAQ: ENDP) ("Endo" or the "Company") today announced that Mark Barberio, who currently serves as an independent member of Endo's

RHEA-AI

neutral

1 2 3 4 5 6 Next